SEC Tracker
Get the app

GeoVax Labs GOVX

GeoVax Labs enters loan agreement

Item 1.01 Enters material agreement, Item 2.03 Takes on debt, Item 3.03 Changes shareholder rights

Form
8-K
Filed
Importance
Major
  1. $1,000,000 loan limit under Revolving Loan Agreement
  2. 12% interest rate with 16% default rate
  3. Requires Qualified Public Equity Offering for $5,000,000
  4. Restricts company from certain corporate actions without lender consent

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when GeoVax Labs files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Earth Science Tech ETST public float $14M, Mar 31, 2026
  2. Edesa Biotech EDSA public float $14M, Mar 31, 2025, over 18 months old
  3. Synergy CHC SNYR public float $13M, Jun 30, 2025
  4. Cellectar Biosciences CLRB public float $13M, Jun 30, 2025
  5. X4 Pharmaceuticals XFOR public float $15M, Jun 30, 2025